GPR20 (US10906974 Biosimilar) Recombinant Monoclonal Antibody

This recombinant monoclonal antibody is developed as a research-grade biosimilar to the reference antibody described in US10906974, specifically targeting GPR20 (G protein-coupled receptor 20). GPR20 is an orphan G protein-coupled receptor whose endogenous ligand and complete physiological functions remain largely uncharacterized. This receptor is predominantly expressed in the central nervous system, particularly in brain regions including the striatum and hypothalamus, suggesting potential roles in neurological signaling and neuroendocrine regulation. Emerging evidence indicates that GPR20 may be involved in various pathophysiological processes, making it a target of interest for neuroscience research and the investigation of neurological disorders.

The reference antibody patent US10906974 provides the framework for this biosimilar development, ensuring consistent targeting specificity for GPR20. This antibody serves as a valuable research tool for investigating GPR20 expression patterns, cellular localization, and functional characterization in various experimental models. It supports studies aimed at elucidating the orphan receptor's biological role and potential therapeutic relevance in neurological research contexts.